Use of liraglutide or semaglutide therapy does not increase risk for thyroid cancer among patients with type 2 diabetes or obesity.

Nearly half of seniors quit GLP-1 weight-loss drugs within a year. Experts reveal why older Americans abandon medications ...

The glucagon-like peptides (GLP-1 and GLP-2) are processed from the proglucagon polypeptide and secreted in equimolar amounts but have opposite effects on chylomicron (CM) production, with GLP-1 ...

GLP-1 receptor agonists may be superior to aspirin for primary prevention of colorectal cancer, according to study results ...

A study found patients with type 2 diabetes treated with GLP-1 receptor agonists were less likely to develop peptic ulcer disease (PUD). As a second-line therapy, GLP-1 drugs also appeared to be more ...

Some dietary supplements may help naturally boost GLP-1, but more research is needed to better understand their potential ...